This website uses cookies in order to provide you with the best possible user experience. To agree to our use of cookies, continue browsing as normal. Visit our Cookies Policy to learn more about the cookies we use and for information about how to change your preferences.
This website uses cookies in order to provide you with the best possible user experience. To agree to our use of cookies, continue browsing as normal. Visit our Cookies Policy to learn more about the cookies we use and for information about how to change your preferences.

NEWS

All developments in the becoming of Eurofins Amatsigroup's future

Amatsigroup manufactures world's first injectable clinical batch under single use isolator

Amatsigroup manufactures world's first injectable clinical batch under single use isolator Fast-growing French company develops innovative single-use technology solutions for aseptic formulation & manufacturing needs for bio/pharmaceutica…
Read more

Manufacturing Chemist Pharma - Propanc signs contract manufacturing agreement with AmatsiQBiologicals

"Australian cancer drug developer Propanc Health Group has signed a contract manufacturing agreement with Belgian firm AmatsiQBiologicals. AmatsiQBiologicals will develop and manufacture under GMP (Good Manufacturing Practice) some of Propanc's enz…
Read more

Amatsigroup acquires Disposable-Lab and enhances its leadership in development services for injectable drug products

Amatsigroup acquires Disposable-Lab and enhances its leadership in development services for injectable drug products Disposable-Lab, a fast-growing French company providing innovative single use technology solutions for aseptic formulation &…
Read more
You have been succesfully registered
There has been a problem, try again later

Amatsigroup acquires Q-Biologicals and strengthens its biologicals offer

Amatsigroup acquires Q-Biologicals and strengthens its offering for international pharmaceutical groups Q-Biologicals, a leading-edge provider of process development and biomanufacturing services Amatsigroup strengthens its position in the d…
Read more

(FR) Chimie Pharma Hebdo - Amatsigroup : «Notre objectif est d’atteindre 50M€ de chiffre d’affaires en 2018»

Sorry, this entry is only available in French.
Read more

Amatsigroup significant events of 2015 and outlook for 2016

Amatsigroup : significant events of 2015 and outlook for 2016 International expansion Reinforcement of R&D activities and operational capacities through two acquisitions: o SEPS Pharma in Belgium o Saint Augustin in France 27% expec…
Read more
1 2

CONTACT US

Your message has been sent.

I’m
your name
from
your company,
your region
. I would like to discuss
select a topic
so please call me at
your phone number
or send an e-mail to
your e-mail address
and
leave your message.